Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.39 |
| ▸ | ACR | P10323 | 2/20 | 0.39 |
| ▸ | AR | P10275 | 2/20 | 0.38 |
| ▸ | ELANE | P08246 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25986436 | 0.92 | MAPT (0.41) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL12442868 | 0.85 | HSD17B10 (0.38) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL12442872 | 0.83 | ELANE (0.42) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL24289734 | 0.81 | ESR1 (0.41) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL12442878 | 0.80 | MAPT (0.38) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL532804 | 0.80 | LMNA (0.53) | MAPTL3MBTL1NPSR1ALDH1A1CA1 | |
| SCHEMBL10236283 | 0.80 | MAPT (0.51) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 | |
| SCHEMBL2356535 | 0.80 | ELANE (0.44) | MAPTALDH1A1CA1CA2ELANE | |
| SCHEMBL2833915 | 0.80 | KMT2A (0.49) | MAPTALDH1A1CA1CA2KMT2A | |
| SCHEMBL12442882 | 0.79 | MAPT (0.37) | MAPTTDP1L3MBTL1NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-08-03 | — | — | US | disclosed |
| WO-2022075382-A1 | ESTER COMPOUND AND RESIN COMPOSITION | 味の素株式会社 | 2022-04-14 | — | — | WO | disclosed |
| US-8698142-B2 | Organic semiconductor element, method of manufacturing organic semiconductor element, electronic device, electronic equipment and insulating layer forming composition | SEIKO EPSON CORPORATION (JP) | 2014-04-15 | — | — | US | disclosed |
| EP-1600471-B1 | Fluorine-containing compound | NIPPON CATALYTIC CHEM IND (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-20110175092-A1 | ORGANIC SEMICONDUCTOR ELEMENT, METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR ELEMENT, ELECTRONIC DEVICE, ELECTRONIC EQUIPMENT AND INSULATING LAYER FORMING COMPOSITION | E INK CORPORATION | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242705-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AFF4, AFF1, AFF2 | MAPT 2274/4885TDP1 3118/4885L3MBTL1 3326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.